This contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin pens to the Defense Logistics Agency (DLA), a defense agency. The $2,045.60 firm fixed-price contract has a completion date of January 28, 2025. The awardee is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,187.60 and an ultimate completion date of January 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. The $1,645.92 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the U.S. government. The $1,019.64 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical on June 18, 2024. The contract is a firm-fixed price delivery order with a completion date of June 20, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued...
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024, with a completion date of November 13, 2024. The contract has a ceiling value of $1,023.24 and is structured as a firm fixed-price delivery order. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA), a defense agency. The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 3, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract is a delivery order valued at $2,110.95 with a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, for the...
This federal contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin pens to the Defense Logistics Agency (DLA). The $1,290.16 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has a period of performance through May 20, 2022 and was competitively awarded without any set-aside designation. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) related to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,958.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml insulin injector pens to the Defense Logistics Agency (DLA). The single-award, firm-fixed-price contract has a ceiling value of $5,234.25 and a period of performance through January 25, 2024. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 through November...